 | • レポートコード：C-PMR-JN053 • 出版社/出版日：Persistence Market Research / 2018年10月 • レポート形態：英文、PDF、214ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：ライフサイエンス・トランスフォーメーションヘルス |
| Individual（１名、印刷不可） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（５名） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
A recent market study published by Persistence Market Research titled “Post Herpetic Neuralgia Treatment Market: Global Industry Analysis 2013-2017 & Forecast 2018-2026” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Post herpetic neuralgia treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the Post herpetic neuralgia treatment market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Post herpetic neuralgia treatment market in the upcoming years. The report provides detailed information about the current and future growth prospects of the post herpetic neuralgia treatment market in the most comprehensive way for the better understanding of readers.
Chapter 1 – Executive Summary
The report commences with the executive summary of the post herpetic neuralgia treatment market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Post herpetic neuralgia treatment market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and the definition of the post herpetic neuralgia treatment market in this chapter, which helps readers to understand the basic information about the post herpetic neuralgia treatment market dynamics, supply chain, cost structure, pricing analysis, list of key distributor and suppliers, list of key market participants included in the report.
Chapter 3 – Global Post Herpetic Neuralgia Treatment Market Analysis (2013-2017) & Forecast (2018-2026), By Treatment Type
Based on the treatment type, the post herpetic neuralgia treatment market is segmented into drugs, patches and steroid injectable. In this chapter, readers can find information about key trends and developments in the post herpetic neuralgia treatment market and market attractive analysis based on the drugs, patches and steroid injectable. In this chapter, readers can find information about key trends and developments in the post herpetic neuralgia treatment market and market attractive analysis based on the product type for each region.
Chapter 4 – Global Post Herpetic Neuralgia Treatment Market Analysis (2013-2017) & Forecast (2018-2026), By Distribution Channel
Based on the distribution channel, the post herpetic neuralgia treatment market is segmented into institutional sales, and retail sales. In this chapter, readers can find information about key trends and developments in the post herpetic neuralgia treatment market and market attractive analysis based on distribution channel. In this chapter, readers can find information about key trends and developments in the post herpetic neuralgia treatment market and market attractive analysis based on the distribution channel for each region.
Chapter 5 – Global Post Herpetic Neuralgia Treatment Market Analysis (2013-2017) & Forecast (2018-2026), By Region
This chapter explains how the post herpetic neuralgia treatment market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific Excluding China (APEC), China and the Middle East & Africa (MEA).
Chapter 6 – North America Post Herpetic Neuralgia Treatment Market Analysis 2013-2017 & Forecast 2018-2026
This chapter includes detailed analysis of the growth of the North America post herpetic neuralgia treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on treatment type, distribution channel and country of post herpetic neuralgia treatment in the North American region.
Chapter 7 – Latin America Post Herpetic Neuralgia Treatment Market Analysis 2013-2017 & Forecast 2018-2026
Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America post herpetic neuralgia treatment market. This chapter also includes the growth prospects of the post herpetic neuralgia treatment market in leading LATAM countries such as Brazil, Mexico, Argentina, and rest of the Latin America region.
Chapter 8 – Europe Post Herpetic Neuralgia Treatment Market Analysis 2013-2017 & Forecast 2018-2026
Important growth prospects of the Post herpetic neuralgia treatment market based on its product types, form, and applications in several European countries, such as Germany, France, Italy, Spain, U.K., Poland, Russia and Rest of Europe is included in this chapter.
Chapter 9 – APEC Post Herpetic Neuralgia Treatment Market Analysis 2013-2017 & Forecast 2018-2026
India, Japan, Australia and New Zealand and rest of Asia Pacific are the leading countries in the APEC region that are the prime subject of assessment to obtain growth prospects of the APEC post herpetic neuralgia treatment market in this chapter. Readers can find thorough information about the growth parameters of the APEC Post herpetic neuralgia treatment market during the period 2018-2026.
Chapter 10 – China Post Herpetic Neuralgia Treatment Market Analysis 2013-2017 & Forecast 2018-2026
Readers can find important factors that can make a huge impact on the growth of the post herpetic neuralgia treatment market in China based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the China post herpetic neuralgia treatment market.
Chapter 11 – MEA Post Herpetic Neuralgia Treatment Market Analysis 2013-2017 & Forecast 2018-2026
This chapter provides information on how the post herpetic neuralgia treatment market will grow in the major countries in MEA region, such as GCC Countries, and South Africa, and rest of MEA during the period 2013-2026.
Chapter 12 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Post herpetic neuralgia treatment market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Endo Pharmaceuticals Inc., Daiichi Sankyo, Acorda Therapeutics, Purdue Pharma L.P, Teikoku Pharma USA, Inc., Janssen Pharmaceuticals, Inc.
Chapter 13 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 14 – Research Methodology
This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the post herpetic neuralgia treatment market.
レポート目次Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Post Herpetic Neuralgia Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.2. Key Trends
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Global Pharmaceutical Outlook
6. Key Inclusions
6.1. Disease Epidemiology
6.2. PEST Analysis
6.3. Regulatory Landscape
7. North America Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
7.4.1. Drugs
7.4.1.1. Anticonvulsants
7.4.1.2. Antidepressants
7.4.1.3. Opioids
7.4.2. Patches
7.4.2.1. Lidocaine Patches
7.4.2.2. Capsaicin Patches
7.4.3. Steroid Injectable
7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
7.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.6.1. Institutional Sales
7.6.1.1. Hospital Pharmacies
7.6.1.2. Clinics
7.6.2. Retail Sales
7.6.2.1. Retail Pharmacies
7.6.2.2. Drug Stores
7.6.2.3. Mail Order Pharmacies
7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Treatment Type
7.8.3. By Distribution Channel
7.9. Key Representative Market Participants
8. Latin America Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
8.2.1. Argentina
8.2.2. Brazil
8.2.3. Mexico
8.2.4. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
8.4.1. Drugs
8.4.1.1. Anticonvulsants
8.4.1.2. Antidepressants
8.4.1.3. Opioids
8.4.2. Patches
8.4.2.1. Lidocaine Patches
8.4.2.2. Capsaicin Patches
8.4.3. Steroid Injectable
8.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
8.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.6.1. Institutional Sales
8.6.1.1. Hospital Pharmacies
8.6.1.2. Clinics
8.6.2. Retail Sales
8.6.2.1. Retail Pharmacies
8.6.2.2. Drug Stores
8.6.2.3. Mail Order Pharmacies
8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Treatment Type
8.8.3. By Distribution Channel
8.9. Key Representative Market Participants
9. Europe Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. Spain
9.2.5. U.K.
9.2.6. Poland
9.2.7. Russia
9.2.8. Rest of Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
9.4.1. Drugs
9.4.1.1. Anticonvulsants
9.4.1.2. Antidepressants
9.4.1.3. Opioids
9.4.2. Patches
9.4.2.1. Lidocaine Patches
9.4.2.2. Capsaicin Patches
9.4.3. Steroid Injectable
9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
9.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.6.1. Institutional Sales
9.6.1.1. Hospital Pharmacies
9.6.1.2. Clinics
9.6.2. Retail Sales
9.6.2.1. Retail Pharmacies
9.6.2.2. Drug Stores
9.6.2.3. Mail Order Pharmacies
9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Treatment Type
9.8.3. By Distribution Channel
9.9. Key Representative Market Participants
10. Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
10.2.1. India
10.2.2. Australia and New Zealand
10.2.3. Japan
10.2.4. Rest of Asia Pacific Excluding China
10.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
10.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
10.4.1. Drugs
10.4.1.1. Anticonvulsants
10.4.1.2. Antidepressants
10.4.1.3. Opioids
10.4.2. Patches
10.4.2.1. Lidocaine Patches
10.4.2.2. Capsaicin Patches
10.4.3. Steroid Injectable
10.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.6.1. Institutional Sales
10.6.1.1. Hospital Pharmacies
10.6.1.2. Clinics
10.6.2. Retail Sales
10.6.2.1. Retail Pharmacies
10.6.2.2. Drug Stores
10.6.2.3. Mail Order Pharmacies
10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
10.8. Market Attractiveness Analysis
10.8.1. By Country
10.8.2. By Treatment Type
10.8.3. By Distribution Channel
10.9.Key Representative Market Participants and Intensity Map
11. Middle East & Africa Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
11.2.1. South Africa
11.2.2. GCC Countries
11.2.3. Rest of MEA
11.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
11.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
11.4.1. Drugs
11.4.1.1. Anticonvulsants
11.4.1.2. Antidepressants
11.4.1.3. Opioids
11.4.2. Patches
11.4.2.1. Lidocaine Patches
11.4.2.2. Capsaicin Patches
11.4.3. Steroid Injectable
11.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.6.1. Institutional Sales
11.6.1.1. Hospital Pharmacies
11.6.1.2. Clinics
11.6.2. Retail Sales
11.6.2.1. Retail Pharmacies
11.6.2.2. Drug Stores
11.6.2.3. Mail Order Pharmacies
11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
11.8. Market Attractiveness Analysis
11.8.1. By Country
11.8.2. By Treatment Type
11.8.3. By Distribution Channel
11.9.Key Representative Market Participants
12. China Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
12.2.1. Drugs
12.2.1.1. Anticonvulsants
12.2.1.2. Antidepressants
12.2.1.3. Opioids
12.2.2. Patches
12.2.2.1. Lidocaine Patches
12.2.2.2. Capsaicin Patches
12.2.3. Steroid Injectable
12.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
12.4. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.4.1. Institutional Sales
12.4.1.1. Hospital Pharmacies
12.4.1.2. Clinics
12.4.2. Retail Sales
12.4.2.1. Retail Pharmacies
12.4.2.2. Drug Stores
12.4.2.3. Mail Order Pharmacies
12.5. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Treatment Type
12.6.3. By Distribution Channel
12.7.Key Representative Market Participants
13. Forecast Factors: Relevance and Impact
14. Forecast Assumptions
15. Market Structure Analysis
15.1. Market Structure by Tier of Companies
15.2. Market Share Analysis % (2017)
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Company Deep Dive
16.3.1. Pfizer Inc.
16.3.1.1. Overview
16.3.1.2. Product and Application Portfolio
16.3.1.3. Production Footprint
16.3.1.4. Sales Footprint
16.3.1.5. Channel Footprint
16.3.1.6. Strategy
16.3.1.6.1. Marketing Strategy
16.3.1.6.2. Product Strategy
16.3.1.6.3. Channel Strategy
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.2.1. Overview
16.3.2.2. Product and Application Portfolio
16.3.2.3. Production Footprint
16.3.2.4. Sales Footprint
16.3.2.5. Channel Footprint
16.3.2.6. Strategy
16.3.2.6.1. Marketing Strategy
16.3.2.6.2. Product Strategy
16.3.2.6.3. Channel Strategy
16.3.3. Mylan N.V.
16.3.3.1. Overview
16.3.3.2. Product and Application Portfolio
16.3.3.3. Production Footprint
16.3.3.4. Sales Footprint
16.3.3.5. Channel Footprint
16.3.3.6. Strategy
16.3.3.6.1. Marketing Strategy
16.3.3.6.2. Product Strategy
16.3.3.6.3. Channel Strategy
16.3.4. Endo Pharmaceuticals Inc.
16.3.4.1. Overview
16.3.4.2. Product and Application Portfolio
16.3.4.3. Production Footprint
16.3.4.4. Sales Footprint
16.3.4.5. Channel Footprint
16.3.4.6. Strategy
16.3.4.6.1. Marketing Strategy
16.3.4.6.2. Product Strategy
16.3.4.6.3. Channel Strategy
16.3.5. Daiichi Sankyo
16.3.5.1. Overview
16.3.5.2. Product and Application Portfolio
16.3.5.3. Production Footprint
16.3.5.4. Sales Footprint
16.3.5.5. Channel Footprint
16.3.5.6. Strategy
16.3.5.6.1. Marketing Strategy
16.3.5.6.2. Product Strategy
16.3.5.6.3. Channel Strategy
16.3.6. Acorda Therapeutics
16.3.6.1. Overview
16.3.6.2. Product and Application Portfolio
16.3.6.3. Production Footprint
16.3.6.4. Sales Footprint
16.3.6.5. Channel Footprint
16.3.6.6. Strategy
16.3.6.6.1. Marketing Strategy
16.3.6.6.2. Product Strategy
16.3.6.6.3. Channel Strategy
16.3.7. Purdue Pharma L.P
16.3.7.1. Overview
16.3.7.2. Product and Application Portfolio
16.3.7.3. Production Footprint
16.3.7.4. Sales Footprint
16.3.7.5. Channel Footprint
16.3.7.6. Strategy
16.3.7.6.1. Marketing Strategy
16.3.7.6.2. Product Strategy
16.3.7.6.3. Channel Strategy
16.3.8. Teikoku Pharma USA, Inc.
16.3.8.1. Overview
16.3.8.2. Product and Application Portfolio
16.3.8.3. Production Footprint
16.3.8.4. Sales Footprint
16.3.8.5. Channel Footprint
16.3.8.6. Strategy
16.3.8.6.1. Marketing Strategy
16.3.8.6.2. Product Strategy
16.3.8.6.3. Channel Strategy
16.3.9. Janssen Pharmaceuticals, Inc.
16.3.9.1. Overview
16.3.9.2. Product and Application Portfolio
16.3.9.3. Production Footprint
16.3.9.4. Sales Footprint
16.3.9.5. Channel Footprint
16.3.9.6. Strategy
16.3.9.6.1. Marketing Strategy
16.3.9.6.2. Product Strategy
16.3.9.6.3. Channel Strategy
17. Global Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Region
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
17.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
17.3.1. North America
17.3.2. Latin America
17.3.3. Europe
17.3.4. Asia Pacific Excluding China
17.3.5. Middle East & Africa
17.3.6. China
17.4. Market Attractiveness Analysis By Region
18. Global Post Herpetic Neuralgia Treatment Analysis 2013–2017 and Forecast 2018–2026, By Treatment Type
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2017
18.2.1. Drugs
18.2.1.1. Opioids
18.2.1.2. Anticonvulsants
18.2.1.3. Antidepressants
18.2.2. Patches
18.2.2.1. Lidocaine Patches
18.2.2.2. Capsaicin Patches
18.2.3. Steroid Injectable
18.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
18.4. Market Attractiveness Analysis By Treatment Type
19. Global Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
19.2.1. Institutional Sales
19.2.1.1. Hospital Pharmacies
19.2.1.2. Clinics
19.2.2. Retail Sales
19.2.2.1. Retail Pharmacies
19.2.2.2. Drug Stores
19.2.2.3. Mail Order Pharmacies
19.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
19.4. Market Attractiveness Analysis By Distribution Channel
20. Global Post Herpetic Neuralgia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
20.1. Market Value Share Analysis By All Segment
20.2. Y-o-Y Growth Analysis By All Segment
20.3. Absolute $ Opportunity
21. Research Methodology
List of TablesTable 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Prevalence of Post Herpetic Neuralgia in North America, 2017
Table 04: Prevalence of Post Herpetic Neuralgia in Latin America, 2017
Table 05: Prevalence of Post Herpetic Neuralgia in Asia Pacific excluding China , 2017
Table 06: Prevalence of Post Herpetic Neuralgia in Europe, 2017
Table 07: North America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08: North America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 09: North America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 10: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 11: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 12: Latin America Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 13: Europe Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: Europe Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 15: Europe Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 16: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 17: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 18: Asia Pacific Excluding China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 19: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 20: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 21: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 22: China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23: China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 24: China Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution channel
Table 25: Competition Dashboard
Table 26: Competition Dashboard
Table 27: Post Herpetic Neuralgia Treatment Market Value (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region
Table 28: Global Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 29: Middle East & Africa Post Herpetic Neuralgia Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel